200,000+ products from a single source!

sales@angenechem.com

Home > Other Building Blocks > 141925-59-9

141925-59-9

141925-59-9 | L-Lysinamide, L-alanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-

CAS No: 141925-59-9 Catalog No: AG001HE9 MDL No:

Product Description

Catalog Number:
AG001HE9
Chemical Name:
L-Lysinamide, L-alanyl-L-histidyl-3-(2-naphthalenyl)-D-alanyl-L-alanyl-L-tryptophyl-D-phenylalanyl-
CAS Number:
141925-59-9
Molecular Formula:
C51H62N12O7
Molecular Weight:
955.1142
IUPAC Name:
(2S)-6-amino-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-[[(2R)-2-[[(2S)-2-[[(2S)-2-aminopropanoyl]amino]-3-(1H-imidazol-5-yl)propanoyl]amino]-3-naphthalen-2-ylpropanoyl]amino]propanoyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-3-phenylpropanoyl]amino]hexanamide
InChI:
InChI=1S/C51H62N12O7/c1-30(53)46(65)60-44(26-37-28-55-29-57-37)51(70)63-42(24-33-19-20-34-14-6-7-15-35(34)22-33)48(67)58-31(2)47(66)61-43(25-36-27-56-39-17-9-8-16-38(36)39)50(69)62-41(23-32-12-4-3-5-13-32)49(68)59-40(45(54)64)18-10-11-21-52/h3-9,12-17,19-20,22,27-31,40-44,56H,10-11,18,21,23-26,52-53H2,1-2H3,(H2,54,64)(H,55,57)(H,58,67)(H,59,68)(H,60,65)(H,61,66)(H,62,69)(H,63,70)/t30-,31-,40-,41+,42+,43-,44-/m0/s1
InChI Key:
NWQWNCILOXTTHF-HLCSKTDOSA-N
SMILES:
NCCCC[C@@H](C(=O)N)NC(=O)[C@@H](Cc1ccccc1)NC(=O)[C@H](Cc1c[nH]c2c1cccc2)NC(=O)[C@@H](NC(=O)[C@@H](Cc1ccc2c(c1)cccc2)NC(=O)[C@H](Cc1c[nH]cn1)NC(=O)[C@@H](N)C)C
UNII:
39EVI31P0W

Properties

Complexity:
1750  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
7  
Defined Bond Stereocenter Count:
0
Exact Mass:
954.486g/mol
Formal Charge:
0
Heavy Atom Count:
70  
Hydrogen Bond Acceptor Count:
10  
Hydrogen Bond Donor Count:
11  
Isotope Atom Count:
0
Molecular Weight:
955.134g/mol
Monoisotopic Mass:
954.486g/mol
Rotatable Bond Count:
25  
Topological Polar Surface Area:
314A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.8  

Literature

Title Journal
GH-releasing peptides improve cardiac dysfunction and cachexia and suppress stress-related hormones and cardiomyocyte apoptosis in rats with heart failure. American journal of physiology. Heart and circulatory physiology 20051001
Emerging drugs for sarcopenia: age-related muscle wasting. Expert opinion on emerging drugs 20041101
Isolated growth hormone deficiency in Chilean patients: clinical and molecular analysis. Journal of pediatric endocrinology & metabolism : JPEM 20030101

© 2019 Angene International Limited. All rights Reserved.